Leslie Shaw awarded NIH grant to explore new therapeutic strategy for breast cancer
Date Posted: September 01, 2024
Leslie Shaw, PhD, has received NIH funding from the National Cancer Institute (NCI) to investigate the role of IRS2 and mitotic regulation in breast cancer. The grant will explore the mechanism by which IRS2, a signaling adaptor protein, regulates chromosome segregation during cell division, and evaluate the feasibility of targeting IRS2 as a therapeutic strategy for the treatment of triple negative breast cancer, an aggressive type of breast cancer.